HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 54, Issue 11, 2013, Pages 2565-2567

  Roy, Sujayita ^a   Di Cello, Francescopaolo ^a   Kowalski, Jeanne ^a,d   Hristov, Alexandra C ^a,e   Tsai, Hua Ling ^a   Bhojwani, Deepa ^b   Meyer, Julia A ^c   Carroll, William L ^c   Belton, Amy ^a   Resar, Linda M S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER RECURRENCE; CHILDHOOD CANCER; GENE OVEREXPRESSION; HIGH MOBILITY GROUP A1 GENE; HUMAN; LETTER; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION; HMGA PROTEINS; HUMANS; INFANT; NEOPLASM RECURRENCE, LOCAL; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84885663039     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.782610     Document Type: Letter

References (17)

1. Hunger SP, Loh ML, Whitlock JA, et al. Children?s Oncology Group?s 2012 blueprint for research: Acute lymphoblastic leukemia. Pediatr Blood Cancer 2012 Dec 19. DOT: 10.1002/pbc.24420 [Epub ahead of print] DOT: 10.1002/pbc.24420.
2. Resar LM. The high mobility group Al gene: Transforming inflammatory signals into cancer? Cancer Res 2010;70:436-439.
3. Wood U, Mukherjee M, Dolde CE, et al. HMG-T/Y, a new c-myc target gene and potential oncogene. Mol Cell Biol 2000;20: 5490-5502.
4. XuY, Sumter ET, Bhattacharya R, et al. The HMG-T oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res 2004;64: 3371-3375.
5. Hillion J, Dhara 5, Sumter Eli, et al. The high-mobility group Ala! signal transducer and activator of transcription-3 axis: An achilles heel for hematopoietic malignancies? Cancer Res 2008;68:1 0121-10127.
6. Schuldenfrei A, Belton A, Kowalski J, et al. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis. BMC Genomics 2011; 12:549.
7. Di Cello F, Dhara 5, Hristov AC, et al. Tnactivation of the Cdkn2a locus cooperates with HMGA1 to drive I-Cell leukemogenesis. Leuk Lymphoma 2013 Jan 11. DOT: 10.3109/10428194.2013.764422[Epub ahead of print] DOT: 10.3109/10428194.2013.764422.
8. Nelson DM, Joseph B, Hillion J, et al. Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia. Leuk Lymphoma 2011;52:1999-2006.
9. Belton A, Gabrovsky A, Bae YK, et al. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS One 2012;7:E30034.
10. Karp JE, Smith BD, Resar LS, et al. Phase 1 and pharmacokinetic study of bolus-1nfusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias. Blood 2011;117:3302-3310.
11. Shah SN, Kerr C, Cope L, et al. HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PUoS One 2012;7:E48533.
12. Somervaille IC, Matheny CJ, Spencer GJ, et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 2009;4:129-140.
13. Nagel 5, Scherr M, Kel A, et al. Activation of IUX3 and NKX2-5 in t(5;14)(q35;q32) I-Cell acute lymphoblastic leukemia by remote 3?-BCUllB enhancers and coregulation byPU.l and HMGA1. Cancer Res 2007;67:1461-1471.
14. Hogan LE, Meyer JA, Yang J, et al. Tntegrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood 2011;l 18:5218-5226.
15. Andersson A, Olofsson T, Lindgren D, et al. Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proc Natl Acad Sci USA 2005;102:19069-19074.
16. Maia 5, Haining WN, Ansén 5, Xia Z, et al. Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia. Cancer Res 2005;65:10050-10058.
17. Haferlach T, Kohlmann A, Wieczorek L, et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: Report from the Tnternational Microarray Tnnovations in Leukemia Study Group. J Clin Oncol 2010;28: 2529-2537.